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Abstract. Over the last two decades, tens of millions of dollars have been invested in understanding 20 
virulence in the human pathogen, Pseudomonas aeruginosa. However, the top “hits” obtained in a 21 
recent TnSeq analysis aimed at identifying those genes that are conditionally essential for infection 22 
did not include most of the known virulence factors identified in these earlier studies. Instead, it seems 23 
that P. aeruginosa faces metabolic challenges in vivo, and unless it can overcome these, it fails to 24 
thrive and is cleared from the host. In this review, we look at the kinds of metabolic pathways that the 25 
pathogen seems to find essential, and comment on how this knowledge might be therapeutically 26 
exploited.          27 
A changing landscape. Pseudomonas aeruginosa is an opportunistic human pathogen – one that has 28 
the dubious accolade of featuring regularly among the “top ten” offenders in lists of common hospital 29 
“superbugs” worldwide. The organism is capable of causing infections in a wide range of tissue types 30 
(especially in immunocompromised hosts) although it exhibits a particular predilection for soft tissues, 31 
where the resulting infections can become either acute or chronic. By definition, chronic infections 32 
fail to clear through normal immune intervention or following antibiotic treatment, and can often 33 
persist for months or even years without resolution. For example, by their ‘teens, the airways of many 34 
cystic fibrosis (CF) patients often become chronically-colonized by P. aeruginosa, and these infections 35 
can persist for decades, in spite of regular aggressive antibiotic scourings’ [1]. By contrast, acute 36 
infections often begin locally, but can rapidly spread to become systemic. Such infections can kill in a 37 
matter of days, and for this reason, P. aeruginosa remains the scourge of hospital burns units. The key 38 
question is, why are the outcomes of these two types of infection – chronic and acute – so radically 39 
different? Recent efforts to address this question have forced us to reconsider our previously rather 40 
“anthropocentric” notions about which microbial factors really are important for maintaining 41 
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successful infection. It turns out that the answer(s) to this question are not necessarily what we 42 
thought. In this review we assess how these recent contributions may lead to a change in our 43 
perception of the “virulence paradigm” that has guided research into P. aeruginosa pathogenicity for 44 
the last few decades.      45 
Some History. First, a bit of background. P. aeruginosa has long been known to be the archetypal 46 
“secretor” and its large (ca. 6.4 Mbp) genome encodes an extensive repertoire of secreted virulence 47 
factors [2]. Of these, proteases seem to play a particularly important role. Indeed, of the 5568 open 48 
reading frames (ORFs) encoded in the genome of the type strain, PAO1, 155 (2.8%) are listed as 49 
proteases in the MEROPS database [3]. Moreover, in the right conditions, the manifold secretory 50 
systems (six at the last count) encoded by P. aeruginosa churn out vast quantities of these tissue-51 
damaging exoenzymes, which in addition to the proteases, also include phospholipases, exotoxins and 52 
endotoxins (Figure 1). A vivid snapshot of the complexity and diversity of the secretome can be 53 
garnered by inspection of any of the manifold 2D-PAGE analyses of P. aeruginosa exoproteins that 54 
have been carried out over the years [4, 5]. The importance of these virulence factors in infection was 55 
inferred from that fact that mutants defective in their synthesis, regulation or secretion often 56 
displayed reduced pathogenicity in e.g., rodent pulmonary models of infection. This was especially 57 
true of “pleiotropic” mutants affecting multiple virulence phenotypes. For example, the cell-cell 58 
signalling mechanism, quorum sensing (QS) has been shown to exert decisive control over the 59 
synthesis of many secreted virulence factors in P. aeruginosa [4, 6]. Consistent with this, QS mutants 60 
display drastically reduced virulence in vivo [7, 8]. The inescapable conclusion from these studies was 61 
that “virulence factors” are a (if not the) key tactical weapon in the infection strategy of P. aeruginosa, 62 
and this line of thinking has dominated the direction of research in the area since its inception.  63 
In parallel with the work being carried out on virulence factors, an influential hypothesis began to 64 
develop which posited that infection type (acute versus chronic) may be integrally-linked with growth 65 
mode. Essentially (so the argument goes) chronic infections are mostly associated with the sessile or 66 
“biofilm-like” mode of microbial growth, whereas acute infections involve cells whose physiology 67 
more closely resembles that observed in planktonic cultures [9, 10] (Figure 2). This was (and remains) 68 
an attractive hypothesis for two reasons. First, planktonic cultures of P. aeruginosa are known to 69 
secrete virulence factors in far greater quantity than their sessile counterparts; a feature that 70 
correlated well with the apparently more aggressive nature of acute infections. [Recent work has also 71 
shown that biofilms not only secrete fewer exoproteins, but also that the spectrum of proteins 72 
secreted is different [4].] Second, due to their polysaccharide coating and altered physiology, biofilms 73 
are known to be highly-resistant to antibiotics and also display reduced clearance by the host immune 74 
system. These are precisely the features that we associate with chronic infections. Moreover, and 75 
consistent with the overall notion that chronic infections are associated with reduced virulence, P. 76 
aeruginosa isolates harvested from CF patients frequently display impaired virulence factor 77 
production (often due to mutation of the master pleiotropic regulator of QS, lasR [11]) and/or 78 
increased antibiotic resistance e.g., due to the acquisition of mutations in genes encoding repressors 79 
of normally-cryptic antibiotic efflux pumps [12].  80 
In the light of the above, and if we had access to technologies that would allow us to “ask the cell” 81 
which of its hardware really is important for infection, we would expect to see a list dominated by 82 
virulence factors, genes involved in lifestyle decisions, antibiotic resistance, “social functions” 83 
(quorum sensing) and so on. Fortunately, such a technology does now exist: TnSeq ([13], Figure 3). 84 
This technique exploits the quantitative nature of next-generation DNA sequencing to measure the 85 
abundance of a particular transposon (Tn) insertion mutant among a library comprising hundreds of 86 
 Future Microbiology 
Peer Review Paper 
 
thousands of individual mutants disrupted in different genes. The utility of TnSeq is that if a library of 87 
mutants is introduced into an infection model, those mutants containing Tn insertions in genes that 88 
are conditionally essential for infection should be negatively selected, and this will be reflected by a 89 
reduction in the corresponding abundance of DNA sequence reads associated with those gene(s) 90 
compared with either the input pool or with DNA harvested from a similarly inoculated in vitro axenic 91 
culture. Based on recent TnSeq analyses (see below), it seems that our preconceptions about infection 92 
may have been unnecessarily skewed towards the role(s) played by virulence factors, and that other 93 
areas of microbial physiology make an equal - if not greater - contribution. Moreover, the same work 94 
also put paid to the widely-held assumption that gene expression (transcript levels, measured by 95 
RNASeq for example) during infection are a good proxy for the relative importance of the 96 
corresponding gene in the infection process (as revealed by TnSeq). It turns out that this is not true. 97 
A different picture emerges. Last year, Turner et al. published a ground-breaking study which 98 
combined both TnSeq (i.e., mutant fitness profiling) and RNASeq (transcriptome profiling) to 99 
investigate which P. aeruginosa genes are conditionally important for acute and chronic infections in 100 
mice [14]. In their murine model, they used a subcutaneously infected dorsal burn to mimic an acute 101 
infection. This type of infection led to rapid sepsis and 100% mortality in 48 hr. By contrast, a surgically-102 
delivered dorsal excision was used to mimic a chronic infection. When covered with an adhesive 103 
bandage to prevent contractile healing such wounds deposit granulation tissue, are recalcitrant to 104 
antibiotic clearance, and can persist for many weeks. As a reference sample for comparison of their in 105 
vivo RNASeq and TnSeq data, these workers used planktonic cultures grown to mid-log phase in MOPS-106 
buffered defined medium with succinate as a sole carbon source – a condition in which the physiology 107 
of P. aeruginosa is well-defined.  108 
RNASeq data. Interestingly, the RNASeq analysis revealed that 14% and 19% of ORFs were 109 
differentially-transcribed (>4-fold change) in the acute (24 hr post-infection) and chronic (3 days post-110 
infection) models, respectively. Moreover, there was substantial overlap in the genes that were 111 
differentially regulated in each case, suggesting that the cues sensed by the bacteria in both types of 112 
infection are similar. Reassuringly, many of the modulated genes – the “usual suspects” - were 113 
involved in virulence or protein secretion. Indeed, some of the greatest fold-changes in expression 114 
were associated with known virulence factors, although the direction of modulation was not always 115 
as expected. For example, transcripts encoding pyochelin (siderophore) synthesis, rhamnolipid 116 
synthesis and alkaline protease (all known virulence factors) were strongly up-regulated in both acute 117 
and chronic infection models, whereas the psl biosynthetic genes were strongly down-regulated. The 118 
latter was unexpected because Psl polysaccharide is the main matrix component of P. aeruginosa 119 
biofilms [15], and as noted earlier, biofilms are thought to be associated with the development of 120 
chronic infections. However, these were minor incongruities compared with the picture emerging 121 
from the parallel TnSeq analyses.  122 
TnSeq data. As in the RNASeq, a sizeable proportion of the mutants displayed differential fitness in 123 
the acute and chronic infection models, and some interesting general patterns became evident. For 124 
example, the TnSeq data indicated that flagellum-based motility is clearly extremely important in 125 
acute but not chronic infection. In contrast, the Type III and Type VI secretion systems were important 126 
for fitness in chronic, but not acute infections. This was somewhat unexpected since laboratory 127 
experiments have shown that these two secretion systems are reciprocally-regulated in vitro: Type III 128 
secretion is thought to be primarily associated with planktonic growth (and therefore, with the 129 
development of acute infections) whereas Type VI systems are thought to be primarily associated with 130 
biofilm growth (i.e., chronic infection (Figure 2) and [9, 10]). Presumably, living cells in “real” infections 131 
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are less dogmatic. Alternatively, the distinction between what constitutes planktonic and biofilm-like 132 
growth in vivo is more blurred than we think. Another intriguing finding was that the genes encoding 133 
the psl biosynthetic cluster contribute strongly to fitness in both the acute and chronic infection 134 
models. Recalling that RNASeq indicated that transcription of the psl gene cluster was down-regulated 135 
in these infection types, this too was unexpected. However, the psl example was not unique – indeed, 136 
for most classes of gene, RNASeq was generally found to be a very poor predictor of genes important 137 
for fitness in the wound models. Critically though, there were some notable exceptions to this trend 138 
– primarily involving genes that encode enzymes involved in metabolism - and for the remainder of 139 
this review, we will focus on these.  140 
You are what you eat… For some functional categories of gene – especially those involved in primary 141 
metabolism – expression levels were found to be a good predictor of mutant fitness. Indeed, it seems 142 
that P. aeruginosa “rewires” its metabolic pathways during infection to take advantage of the 143 
particular set of nutrients available in the host environment. So what kinds of nutrient does P. 144 
aeruginosa eat as it tucks into a nice meal of mammal? The RNASeq/TnSeq analysis of Turner et al 145 
allowed – for the first time - the in vivo dietary preferences of P. aeruginosa to be inferred. Projection 146 
of the RNASeq data for metabolic genes onto the KEGG pathways map for P. aeruginosa revealed 147 
some unexpected results. It turns out that P. aeruginosa – previously thought to be an amino acid 148 
lover [16] (which would be commensurate with the plethora of proteases encoded in its genome) – is 149 
particularly partial to long-chain fatty acids. The faoAB genes (encoding the 2-enoyl-CoA hydratase / 150 
3-hydroxyacyl-CoA dehydrogenase subunit (FaoA) and 3-oxoacyl-CoA thiolase subunit (FaoB) of the 151 
fatty acid oxidase complex [17]) were up-regulated in the acute infection model, and the same genes 152 
displayed fitness defects when disrupted by Tn insertions. Moreover, a defined faoA deletion mutant 153 
was attenuated in both chronic and acute infection models, suggesting that fatty acid oxidation plays 154 
a key role in survival in vivo.   155 
2C or not 2C? The problem with utilizing fatty acids is that they are broken down via β-oxidation to 156 
acetyl-CoA units. These acetate moieties are then combined with oxaloacetate to yield citrate, which 157 
then enters the TCA cycle. Normally, as they progress around the cycle, these two acetate-derived C 158 
atoms are liberated as CO2. This means that the two input C atoms (acetate moieties) cannot be used 159 
to generate biomass. The cell can therefore generate energy (i.e., NADH and thence ATP equivalents) 160 
but cannot grow; gluconeogenesis is not possible when fatty acids are the sole C source. However, 161 
bacteria have evolved a clever solution to this problem. Prior to the CO2-producing steps of the TCA 162 
cycle, a proportion of the carbon skeletons are “siphoned off” the main sequence of TCA cycle 163 
reactions in a pathway known as the glyoxylate shunt (Figure 4). Here, isocitrate is cleaved by isocitrate 164 
lyase (encoded by aceA) to yield glyoxylate and succinate (which re-enters the TCA cycle following the 165 
oxidative decarboxylation steps). The glyoxylate is not wasted though; malate synthase G (encoded 166 
by glcB in P. aeruginosa) combines glyoxylate with an additional acetyl-CoA molecule to yield the 167 
gluconeogenic precursor, malate. The net effect of this is that C skeletons are preserved for anabolic 168 
reactions and the creation of biomass [18, 19]. Consistent with this proposed redirection of carbon 169 
flux, Turner et al found that the transcripts encoding enzymes involved in the oxidative 170 
decarboxylation steps of the TCA cycle (isocitrate dehydrogenase(s) and α-ketoglutarate 171 
dehydrogenase) are down-regulated, whereas the transcript encoding the first enzyme of the 172 
glyoxylate shunt (aceA) was up-regulated [14].  173 
The importance of the glyoxylate shunt in infections has been noted before. Lindsey et al. found that 174 
an isocitrate lyase (aceA) mutant displays reduced virulence in a rat lung infection model and noted 175 
that isocitrate lyase activity is often up-regulated in CF-derived isolates adapted to chronic infection 
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[20]. More recently, Fahnoe et al inactivated both aceA and glcB in P. aeruginosa i.e., completely 177 
inactivating the glyoxylate shunt [21]. This double mutant was completely cleared by 48 hr post-178 
infection in a mouse pulmonary infection model, indicating that the shunt is absolutely essential for 179 
colonization in vivo. Remarkably, the same team also identified a collection of small molecules that 180 
could simultaneously inhibit both isocitrate lyase and malate synthase G in laboratory cultures of P. 181 
aeruginosa. Unfortunately, Fahnoe et al. did not report on whether their “top hit” compounds could 182 
resolve in vivo infections – presumably, these compounds may be toxic in mammalian systems, but 183 
the overall approach still looks promising. Indeed, nature has already exploited this strategy; recent 184 
work has shown that the human enzyme Irg1 synthesizes large quantities of itaconate (an inhibitor of 185 
isocitrate lyase) during macrophage activation, directly contributing towards the antimicrobial activity 186 
of these cells (reviewed in [22]). However, and in a remarkable evolutionary tit-for-tat, P. aeruginosa 187 
(along with other pathogens such as Yersinia pestis) has also acquired the ability to degrade itaconate, 188 
and can even live off this compound as a sole C source ([23]). Furthermore, recent data suggest that 189 
P. aeruginosa can also degrade other isocitrate lyase inhibitors, such as nitropropionic acid (produced 190 
by some plants and fungi) via the nitronate monooxygenase activity of the gene encoded by PA4202 191 
(nmoA) [24].    192 
Interestingly, recent 13C flux analyses have indicated that unlike the situation in Escherichia coli, where 193 
aceA is only expressed during growth on acetate (or acetate-producing substrates), in P. aeruginosa, 194 
there is significant flux through the pathway even during growth on glucose [25]. This suggests that 195 
the shunt may play a more general role in the physiology of the organism beyond simply redirecting C 196 
skeletons for gluconeogenesis. Indeed, inhibition of the glyoxylate shunt may deliver a double 197 
whammy to P. aeruginosa; our own team recently showed that isocitrate lyase activity stimulates Type 198 
III Secretion during microaerobic growth, suggesting that the absence of the glyoxylate shunt not only 199 
results in metabolic insufficiency – it also diminishes virulence per se [26]. Moreover, itaconate could 200 
suppress Type III Secretion when added to microaerobic cultures in vitro. Crucially in this regard, the 201 
RNASeq/TnSeq data of Turner et al. strongly suggest that oxygen limitation plays a key role in infection 202 
– the anaerobic regulator [27] encoded by anr was among the most strongly attenuated Tn mutants 203 
that they identified, especially during acute infection [14]. These data suggest that oxygen limitation 204 
may be a common feature of many P. aeruginosa infections.   205 
Quite why P. aeruginosa chooses a metabolic strategy that is dependent upon the glyoxylate shunt 206 
(instead of utilizing more “available” nutrients) is not clear. However, inspection of the rank-ordered 207 
list of attenuated Tn mutants obtained by Turner et al reveals that insertions in glpD (glycerol 3-208 
phosphate dehydrogenase) were also essentially avirulent in vivo. GlpD converts glycerol 3-phosphate 209 
into dihydroxyacetone phosphate, and a mutant in glpD was recently shown to produce lower levels 210 
of certain virulence determinants (pyocyanin and pyoverdine) in vitro [28]. One major possible source 211 
of glycerol in vivo is phospholipids, which are broken down to yield fatty acids and glycerol.  212 
To get a better insight into what kinds of nutrient are on the P. aeruginosa menu in a mouse, Turner 213 
et al. compared the biosynthetic pathways expressed during growth on minimal succinate media 214 
(where most biosynthetic pathways are necessarily “on”) with those expressed in vivo. The logic here 215 
was that biosynthetic pathways are generally only transcribed when the corresponding pathway 216 
product is not available from the environment (after all, why waste valuable metabolic resources 217 
synthesizing say, an amino acid, if the same amino acid is plentiful in the growth media?). Therefore, 218 
by comparing these two datasets, they could infer which nutrients might be available to P. aeruginosa 219 
in vivo during wound infections. The results were surprising; non-available metabolites included 220 
certain amino acids (glutamate, aspartate, tyrosine, phenylalanine and asparagine) as well as purines, 221 
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p-aminobenzoate and B-group vitamins (the precursors for many cofactors). Indeed, and further 222 
confirming these results, in vitro-constructed pabC and purA mutants (deficient in p-aminobenzoate 223 
and purine biosynthesis, respectively) were avirulent in vivo. In contrast, mutants defective in 224 
metabolites predicted to be “available” in vivo were unaffected in virulence. This striking result 225 
strongly suggests that components of the pathways required for synthesis of “non-available” 226 
metabolites may make excellent targets for the development of new anti-pseudomonal agents.  227 
The situation is slightly different in CF infections. More recently, Turner et al. have been using Monte 228 
Carlo simulations to rigorously interrogate a new set of TnSeq data in which the growth requirements 229 
of P. aeruginosa in CF sputum have been investigated. These data have enabled them to refine the 230 
composition of artificial CF sputum medium [29]. The gene fitness requirements in this new medium 231 
now so closely resemble that in “real” CF sputum that they are all but indistinguishable, thereby 232 
providing a far better laboratory model for the study of CF-associated P. aeruginosa infections than 233 
previously possible. In the same study, the authors also compared the list of genes that are 234 
conditionally essential for the survival of two strains of P. aeruginosa (PAO1 and PA14) when grown 235 
in minimal medium containing authentic CF sputum as a sole nutrient source. Interestingly, most of 236 
the conditionally essential genes were located in the conserved “core” genome of both strains. 237 
However, clear differences were observed in the relative essentiality of different genes in each strain. 238 
Moreover, and although common pathways (e.g., those for chorismate, panthothenate, 239 
diaminopimelate, purines, pyridoxal phosphate, riboflavin and certain polyamines) were deemed 240 
essential for infection in both wound [14] and CF infections [29], some important differences were 241 
apparent. For example, as outlined earlier, fatty acid oxidation is essential in wound infections but 242 
seems to play a much less important role during growth in CF sputum. In general, the authors 243 
concluded that CF sputum presents a far less harsh environment compared with that encountered in 244 
wound infections, although cynically, this may simply be a reflection of the fact that the in vitro CF 245 
model used by those workers contains no immune cells, whereas presumably, an exuberant immune 246 
response is mounted in the in vivo wound models. Nevertheless, the results of Turner et al [14, 29] 247 
and Fahnoe et al [21] strongly suggest that the targeting specific domains of metabolism may offer a 248 
real opportunity to develop some truly innovative antimicrobial interventions. In this regard, it is ironic 249 
to note that one of the first antibiotics, sulfanilimide (introduced in the 1930s), targets p-250 
aminobenzoate metabolism.   251 
Real-life infections are more complex. One fly-in-the-ointment in the case for targeting specific 252 
metabolic nodes is that P. aeruginosa isolates which are auxotrophic for certain amino acids arise 253 
frequently in chronic CF infections [30]. Indeed, we too have identified auxotrophs in CF sputum that 254 
are defective in the synthesis of one or more of the 20 common amino acids, as well as in the synthesis 255 
of certain cofactors (MW/E-FU/AF, unpublished data). This is surprising given that the availability of 256 
several amino acids (e.g., Gln, Tyr, Asn, Asp) is predicted by Turner et al. to be limiting in CF sputum 257 
[29]. However, and as noted by Barth & Pitt, CF sputum is certainly rich enough in amino acids to 258 
support the growth of some auxotrophs [31]. Additionally, there is even evidence to suggest that high 259 
total amino acid concentrations in sputum coincide with acute pulmonary exacerbation episodes and 260 
an increased prevalence of auxotrophs [32]. One possibility is that these sputum amino acids are host-261 
derived. If this is so, then the case for targeting P. aeruginosa amino acid biosynthesis for possible 262 
therapeutic intervention is weakened. Alternatively, the sputum amino acids could be microbially-263 
derived. In this regard, biofilm and anaerobic planktonic cultures of P. aeruginosa (PAO1) grown in 264 
defined medium in vitro are known to accumulate large quantities of amino acids [33], presumably 265 
due to overflow metabolism. [We note here that the sputum samples used in the study of Tuner et al. 266 
that were found to be limiting for Gln/Tyr/Asn/Asp were (understandably) obtained from a patient 267 
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with a low bacterial load [29].] This raises the possibility that the population structure of P. aeruginosa 268 
in any given chronically-infected CF patient may be self-stabilized via intra-species cross-feeding. For 269 
example, Tyr- P. aeruginosa auxotrophs could be sustained off the tyrosine provided by Tyr+ 270 
prototrophs, and so on. If this is indeed the case, then amino acids (and presumably, other metabolites 271 
too) can be viewed as bacterially-produced “public goods” in much the same way that virulence 272 
factors have been [34, 35]. While this possibility has not yet been rigorously tested experimentally, 273 
there is good evidence to suggest that the population of P. aeruginosa in a given sputum sample is 274 
both phenotypically and genomically heterogeneous [36-39]. If true and the P. aeruginosa population 275 
structure is stabilized by cross-feeding of nutrients, then by targeting the synthesis of one or more of 276 
these nutrients, the network of interactions that maintains population cohesion should collapse (or at 277 
least undergo radical remodelling). However, a potential counter-argument lies in the fact that CF 278 
infections are rarely associated with P. aeruginosa monocultures; a veritable zoo of microbes can be 279 
identified (usually from their 16S rDNA signatures) in many CF sputa [40, 41], raising further 280 
opportunities for cross-feeding. Consequently, drugs targeting specific domains of metabolism may 281 
need to have rather broad specificity, allowing them to target enzymes in multiple genera of bacteria.  282 
Parting comments. P. aeruginosa is not a professional pathogen; in spite of its genomic arsenal of 283 
putative virulence determinants, it is primarily an opportunist that has to adapt to the host 284 
environment in order to survive. The TnSeq analyses of Turner et al have yielded insights into what 285 
the cell itself finds important during this process. The precise physiological adaptations that appear to 286 
be truly important are tuned to some extent by the subtle nuances attending the different types of 287 
infection in different tissues. However, there is enough common ground between the requirements 288 
in these different infection types to raise the hope that generic new anti-pseudomonal compounds 289 
might be discovered through this avenue of investigation. This notwithstanding, and aside from the 290 
issues raised earlier in this discussion, there are caveats. One is the issue of redundancy. For example, 291 
although FaoA/FaoB clearly play an important role in wound infections, the acyl-CoA dehydrogenases 292 
that necessarily precede the action of these enzymes were not identified as being conditionally 293 
essential in infection. Presumably, this is because multiple copies of genes encoding acyl-CoA 294 
dehydrogenases are present in the P. aeruginosa genome (seven genes are annotated as putative acyl-295 
CoA dehydrogenases in PAO1) and inactivation of any one of these genes may be compensated by the 296 
residual activity of the other isozymes present. A similar argument could be made for ppGpp 297 
generating enzymes. The stress alarmone, ppGpp, is required for amino acid biosynthetic pathway 298 
expression [42] and has been implicated in virulence in many bacterial pathogens (reviewed in [43]). 299 
However, for a noticeable virulence phenotype to be manifest, both ppGpp-generating enzymes (RelA 300 
and SpoT) need to be inactivated [44]. Similarly, cyclic di-GMP is also known to play a key role in 301 
determining lifestyle and virulence in P. aeruginosa, yet this small molecule is made and sensed by a 302 
multitude of gene products [45]. Another potential issue relates to the nature of the medium 303 
employed for growth of the TnSeq reference samples (recall that Turner et al used MOPS-buffered 304 
succinate medium). This is because the “essential gene set” varies somewhat during growth in vitro in 305 
different media (Lee et al, [46]). Although there is an apparent “core” set of ca. 350 genes (many of 306 
which are involved in central carbon metabolism) that seem to be essential in most common 307 
laboratory growth media, Lee et al identified ca. 200 genes that appear to be conditionally essential 308 
in different growth media. Thus, the conclusions of Turner et al will be inevitably biased somewhat by 309 
their specific choice of MOPS-succinate for growth of the reference sample. However, and 310 
commensurate with the results discussed earlier, Lee et al also found that CF sputum is likely to be 311 
rich in amino acids and unsaturated fatty acids [46].     312 
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Future Perspective. These arguments aside, the results of Turner et al. must at the very least cause us 313 
to re-assess our notions about P. aeruginosa virulence. The past two decades of P. aeruginosa 314 
virulence research have been dominated by the role(s) played by quorum sensing and biofilm 315 
formation. However, it turns out that although the “key regulators” associated with these phenotypes 316 
(retS, ladS, lasR, gacA, gacS, rsmA, rsmY, rsmZ etc – [9, 10, 47]) do feature on the “TnSeq attenuated-317 
list”, for the most part they do not make the “top 200” for any infection type. That is not to say that 318 
they do not play an important role in infection under some circumstances – they do, and we know 319 
that. It’s just that some rather more mundane (and perhaps, overlooked?) phenotypes seem to be 320 
more important. This may actually be good news; unlike many of the pleiotropic virulence regulators 321 
that have become a favoured target for antimicrobial research over the last two decades, the enzymes 322 
of central metabolism are generally (i) highly conserved across the bacterial genera, and (ii) contain 323 
discrete “drug-able” binding pockets that are amenable to drug development. Moreover, we have 324 
historical proof-of-principle that the targeting of metabolic nodes (re: the sulphonamides) works. 325 
Given the dearth of new antimicrobials in the pipeline, coupled with the inexorable spread of 326 
resistance to existing antibiotics, it seems likely that over the next few years we will see a renewed 327 
interest in targeting central metabolism.  328 
Executive Summary.  329 
● Pseudomonas aeruginosa is an opportunistic pathogen which produces a wealth of secreted 330 
virulence factors and secondary metabolites. These secreted factors have been assumed to play a 331 
pivotal role in infection. 332 
● New technologies are allowing us to “ask the bacterial cell” which of its genes are important for 333 
infection in mammalian systems. For example, RNASeq allows quantitation of transcript levels 334 
whereas TnSeq reports on the contribution of specific genes towards fitness in vivo. 335 
● In a recent analysis, RNASeq and TnSeq were used in parallel to investigate which P. aeruginosa 336 
genes are required for optimal virulence in a murine infection model. Surprisingly, for most classes of 337 
gene (including known virulence factors) this analysis revealed that there was very little correlation 338 
between transcript abundance and the contribution of the corresponding gene towards overall 339 
fitness. However, for certain “metabolic genes”, these factors were strongly correlated.  340 
● During some types of infection, P. aeruginosa exhibits a predilection for metabolizing fatty acids. 341 
Mutants in the fatty acid oxidase complex are severely attenuated in virulence.  In addition, the 342 
glyoxylate shunt (an anaplerotic pathway which bypasses the oxidative decarboxylation steps of the 343 
TCA cycle) makes an important contribution towards fitness in vivo.   344 
● Certain metabolites (amino acids and vitamins) are not available to P. aeruginosa during in vivo 345 
infections, making the biosynthetic pathways producing these compounds excellent potential targets 346 
for the development of novel antimicrobials.  347 
● Not all types of infecQon elicit the same metabolic requirements in P. aeruginosa. Moreover, the 348 
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 531 
Figure Legends. 532 
Figure 1. Virulence factors and their associated secretion systems in P. aeruginosa. The genes 533 
encoding type I secretion systems (“T1” in the figure) are generally tightly-associated with their 534 
respective substrates (e.g., the aprDEF cluster encodes the alkaline protease T1 secretion system, 535 
which is located immediately adjacent to the genes encoding its secreted substrates, AprX and AprA). 536 
In contrast, the passenger proteins secreted through the type II secretion systems (T2) are distributed 537 
around the genome and carry cleavable N-terminal signal sequences or Tat signals. Two T2 systems 538 
have been described in P. aeruginosa; the Xcp system [48] (which transports most of the proteins 539 
shown in the figure) and the Hxc system [49] which exports the alkaline phosphatase, LapA. The T3 540 
and T6 systems are “injectisomes” which export proteins directly from the bacterial cytosol into the 541 
recipient cell [50], which may be either a host cell or another bacterium. P. aeruginosa encodes one 542 
dedicated type III secretion system (T3SS) comprised of around 40 genes, and three T6SSs (HSI-I, HSI-543 
II and HSI-III) each comprising around 15-20 genes. However, the flagellar apparatus (also a virulence 544 
factor in its own right, but not shown for clarity in the figure) can arguably be defined as a T3SS too. 545 
Finally, P. aeruginosa also encodes two varieties of T5SS [51]; the T5a autotransporter secretes the 546 
cell surface-associated esterase EstA whereas the T5b “two-partner” systems secrete e.g., the 547 
protease LepA (which targets NF-κB) or the chaperone usher protein, CupB5. There are four other T5b 548 
systems known to be encoded in the P. aeruginosa genome. In addition, P. aeruginosa also secretes 549 
polysaccharides such as Psl [15] and Pel [52], which are thought to constitute the biofilm/pellicle 550 
matrix, as well as alginate (whose production is essentially pathognomic of CF).  551 
Figure 2. Reciprocal regulation of virulence factors in laboratory cultures: the “lifestyle paradigm”. 552 
In laboratory growth conditions, planktonic cultures of P. aeruginosa secrete large quantities of tissue-553 
damaging exoproteins, primarily due to the operation of the T1 and T2 secretion systems (see Figure 554 
1). Expression of the T1 and T2 secretion systems and of many of their substrates is controlled by 555 
quorum sensing (QS) [5, 6]. In contrast, expression of the T3 system is only minimally affected by QS. 556 
Instead, T3 secretion – which leads to the subversion of host cell function - thought to be primarily 557 
turned “on” as a consequence of RetS signalling. In the activated state, RetS forms inhibitory 558 
heterodimers with the sensor kinase, GacS. This leads to less GacA phosphorylation and consequently, 559 
less expression of the RsmA antagonistic RNA species, rsmZ and rsmY. RsmA activity therefore 560 
becomes unfettered, leading to increased T3 secretion and motility and a concomitant decrease in T6 561 
secretion/psl gene expression [45]. This reciprocal regulation is further fine-tuned by cyclic di-GMP 562 
levels (low cyclic-di-GMP concentrations favour motility and T3 secretion). In contrast, when a biofilm 563 
forms, LadS signalling dominates. This leads to a decrease in free RsmA levels, and combined with high 564 
cyclic-di-GMP concentrations, promotes increased T6 secretion and psl gene expression. Oddly, QS 565 
has been posited as being important for biofilm formation too, yet in vitro-grown biofilms exhibit only 566 
low levels of T1/T2-dependent protein secretion [4]. It is not yet clear why QS should impact so 567 
differently on protein secretion during planktonic and biofilm growth.  568 
Figure 3. Overview of the TnSeq method. A library of in vitro-generated Tn mutants is prepared and 569 
is used to inoculate a laboratory culture and an animal infection model. After the requisite amount of 570 
time, bacterial DNA is harvested from each sample and the DNA flanking the Tn insertions is PCR 571 
amplified. Bar-coded sequencing primers are then ligated to each PCR product and the mixture is sent 572 
for DNA sequencing (usually using an Illumina sequencer). The quantitative nature of Illumina 573 
sequencing means that the number of reads associated with each Tn insertion can be determined, 574 
allowing the representation of each Tn mutant in the output pool (cf. the input pool or control growth 575 
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condition) to be established. In the figure, Tn insertions in “gene B” are strongly negatively-selected 576 
in the mouse infection model, so the read frequency of Tn insertions in that gene/condition are 577 
negligible. This indicates that gene B is essential for in vivo infection.   578 
Figure 4. Overview of the glyoxylate shunt pathway in P. aeruginosa. In the glyoxylate shunt (pale 579 
orange arrows and metabolites) carbon skeletons are redirected away from the CO2 producing steps 580 
of the TCA cycle and retained for gluconeogenesis. The glyoxylate shunt requires two enzymes: 581 
isocitrate lyase (ICL) and malate synthase (GlcB), and the net effect of their activity is to convert two 582 
molecules of acetyl-CoA into one molecule of malate (a gluconeogenic precursor). In the chronic and 583 
acute wound models, the acetyl-CoA is generated as a consequence of FaoAB-mediated fatty acid 584 
oxidation. Unlike E. coli, in P. aeruginosa there are two isocitrate dehydrogenase enzymes (ICD and 585 
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